Satellite Symposia

Monday Evening, February 29, 2016, 6:00 – 8:00 PM
MPS I: New horizons and opportunities for change
Supported by PTC Therapeutics, Inc.
Tuesday Morning, March 1, 2016, 6:30 – 7:30 AM
Optimizing Treatment in Morquio A: Capturing multi-domain impact through patient-directed outcomes
Supported by BioMarin Pharmaceutical Inc.
Tuesday Lunchtime, March 1, 2016, 11:45 AM – 12:45 PM
Non-immune hydrops fetalis (NIHF) in lysosomal storage diseases
Supported by Ultragenyx Pharmaceutical Inc.
Tuesday Evening, March 1, 2016, 6:30 – 8:30 PM
The Many Faces of Lysosomal Disease: A Global Perspective
Supported by Amicus Therapeutics
Wednesday Morning, March 2, 2016, 6:30 – 7:30 AM
Discovery and Research Platforms in Rare Disease
Supported by Shire
Wednesday Lunchtime, March 2, 2016, 11:30 AM – 12:45 PM
From diagnosis to treatment: a multidisciplinary approach for the management of Type I Gaucher disease
Supported by Shire International
Wednesday Evening, March 2, 2016, 6:30 – 8:30 PM
How Early is Early? When to Start ERT and Other Considerations for Optimizing Treatment of Fabry Disease
CME Satellite Sponsored by MedIQ. Supported by an educational grant from Sanofi Genzyme
Thursday Morning, March 3, 2016, 6:30 – 7:30 AM
Recognizing the signs of CLN2 disease – emerging evidence for a paradigm shift in CLN2 diagnosis
Supported by BioMarin Pharmaceutical Inc.
Thursday Lunchtime, March 3, 2016, 11:45 AM – 12:45 PM
Patients, exogenous enzymes, and substrate synthesis inhibition: A quarter-century of managing Gaucher disease
Supported by Sanofi Genzyme
Titles and content for Satellite Symposia will be posted as information becomes available.
These Satellite Symposia are not part of the official WORLDSymposium™ 2016 program, and WORLDSymposium 2016 does not approve or endorse any commercial products or services discussed during these Symposia or offered for sale by the corporate supporter of the Symposium. These Symposia may or may not offer CME credits; these sessions are not approved for CME through WORLDSymposium 2016.